尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Herzich Paul. Director active across 1 company, notably Solid Biosciences Inc.. Cumulatively, 7 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €59k. Activity tracked since 4 February 2026. The latest transaction was disclosed on 4 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Herzich Paul has filed 7 forms in total, all relating to Solid Biosciences Inc., where he is Chief Technology Officer. In the sampled recent filings, they cover the period from 2023-12-05 to 2026-02-18, with EUR 59452 in sales and EUR 0 in purchases, and the most common transaction nature is Levée d'options.